|

Clinicopathologic and Ancillary Testing of Primary Clear Cell Carcinoma of the Cervix

RECRUITINGSponsored by M.D. Anderson Cancer Center
Actively Recruiting
SponsorM.D. Anderson Cancer Center
Started2021-08-06
Est. completion2026-09-29
Eligibility
SexFEMALE
Healthy vol.Accepted
Locations1 site
View on ClinicalTrials.gov →

NCT05046080

Summary

This study aims to provide a comprehensive report on clinicopathologic features, immunohistochemical/biomarker testing and molecular profile of cervical clear cell carcinoma. This study may help researchers learn more about the molecular profile of cervical clear cell carcinoma.

Eligibility

Sex: FEMALEHealthy volunteers accepted
Inclusion Criteria:

* Patients diagnosed with clear cell carcinoma of the cervix at MDACC

Conditions2

CancerHuman Papillomavirus-Independent Cervical Adenocarcinoma, Clear Cell-Type

Locations1 site

M D Anderson Cancer Center
Houston, Texas, 77030
Anasis Malpica713-792-4655amalpica@mdanderson.org

Browse More Trials

Cancer trials

Trial data from ClinicalTrials.gov. Trial status and eligibility can change — verify directly with the study contact or on ClinicalTrials.gov.

This site does not provide medical advice. Always consult your doctor before considering enrollment in a clinical trial. Learn more on our About page.